Cancer diagnostics News and Research

RSS

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

IBM scientists are collaborating with pathologists at the University Hospital Zurich to test a new prototype tool to accurately diagnose different types of cancer. This work is based on a technology developed by IBM scientists called a microfluidic probe, which slightly resembles the nib of a fountain pen.

23 Oct 2013

Study: Elevated BMI may affect survival in pancreatic cancer patients

New results from a prospective study published in the Journal of Clinical Oncology show that patients with a body mass index (BMI) in the obese range live on average two to three months less after a pancreatic cancer diagnosis, compared with healthy weight patients, even after adjusting for factors that are known to predict survival for patients with this disease, such as age and disease stage.

22 Oct 2013

Genalyte receives NCI grant to develop biomarker panel to profile TAA autoantibodies

Genalyte, Inc., today announced that it has received a $1 million SBIR grant from the National Cancer Institute to develop a biomarker panel to profile tumor antigen-associated autoantibodies.

18 Oct 2013

Simple urine test uses nanotechnology to detect dangerous blood clotting

Life-threatening blood clots can form in anyone who sits on a plane for a long time, is confined to bed while recovering from surgery, or takes certain medications.

17 Oct 2013

New $1.9M research grant to support investigators to detect tumors in earliest stages of formation

The National Cancer Institute's new Provocative Questions research funding program has awarded a prestigious grant to researchers at the Case Comprehensive Cancer Center and Case Western Reserve University's Schools of Medicine and Engineering to study tumor detection at the earliest stages of growth.

16 Oct 2013

Simple blood test can help diagnose early-stage lung and prostate cancers

Early-stage lung and prostate cancers as well as their recurrence can be detected with a simple blood test, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

16 Oct 2013

Experts suggest interventions to help reduce delays in diagnosis of cancer in primary care

Continuity of care so that all patients see the same GP with whom they build up a relationship over time could help reduce delays in the diagnosis of cancer in primary care. In an essay published by the Journal of the Royal Society of Medicine, a team of primary care experts write that this, together with longer consultations and better distribution of information to GPs about referral pathways or new services could have a wide reaching impact on the early diagnosis of cancer and survival.

11 Oct 2013

Report provides new estimates of breast cancer rates among active component service women

Crude incidence rates of breast cancer among U.S. female active component service members have fluctuated slightly over the past 12 years, but have remained relatively stable, according to a new study.

11 Oct 2013

Reducing risk factors like hypertension might lower risk of heart disease for childhood survivors

For childhood cancer survivors, risk factors associated with lifestyle, particularly hypertension, dramatically increase the likelihood of developing serious heart problems as adults, according to a national study led by St. Jude Children's Research Hospital. The findings appear in the current issue of the Journal of Clinical Oncology.

11 Oct 2013

Risk of dying from invasive breast cancer lower among multivitamin/mineral users

Findings from a study involving thousands of postmenopausal women suggest that women who develop invasive breast cancer may benefit from taking supplements containing both multivitamins and minerals.

9 Oct 2013

Boreal Genomics announces completion of $18 million Series C financing round

Boreal Genomics, a privately held provider of technology for non-invasive genomic profiling of tumors from blood plasma of cancer patients, announced today the completion of an $18 million Series C financing round.

5 Oct 2013

Cynvenio launches ClearID Breast Cancer monitoring program

Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.

4 Oct 2013

Obamacare winners and losers

NPR looks at what the federal government can learn from Massachusetts as health insurance exchanges roll out. Other media outlets check in with insurers, Wall Street traders, health care stakeholders and those who had previously been denied coverage in the individual insurance market.

2 Oct 2013

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

The U.S. Food and Drug Administration granted accelerated approval of a Perjeta- (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER2-positive early stage breast cancer.

2 Oct 2013

First Edition: October 1, 2013

Today's headlines detail how the federal government has been shutdown as a result of the ongoing congressional battle over the health law. Still, even as House and Senate lawmakers were unable to overcome this issue to reach a deal to provide funding to continue government operations, Oct. 1 is still the official launch of the overhaul's online insurance marketplaces.

1 Oct 2013

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) heard today.

1 Oct 2013

Researchers discover how aspirin improves survival in patients with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress heard today (Monday).

30 Sep 2013

Health expenditure link to cancer survival in Europe

The more an EU national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology.

30 Sep 2013

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

Astellas Pharma US, Inc. and Medivation, Inc. today announced results of a national survey of men with advanced prostate cancer and caregivers of men with advanced prostate cancer.

26 Sep 2013

Older women living in poorest areas of Appalachia have higher incidence of later stage breast cancer

Older women living in the poorest areas of Appalachia in the U.S. fail to get regular breast cancer screening and have a higher incidence of later stage breast cancer, reports a new study in Health Services Research.

26 Sep 2013

Cancer diagnostics News and Research

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

Study: Elevated BMI may affect survival in pancreatic cancer patients

Genalyte receives NCI grant to develop biomarker panel to profile TAA autoantibodies

Simple urine test uses nanotechnology to detect dangerous blood clotting

New $1.9M research grant to support investigators to detect tumors in earliest stages of formation

Simple blood test can help diagnose early-stage lung and prostate cancers

Experts suggest interventions to help reduce delays in diagnosis of cancer in primary care

Report provides new estimates of breast cancer rates among active component service women

Reducing risk factors like hypertension might lower risk of heart disease for childhood survivors

Risk of dying from invasive breast cancer lower among multivitamin/mineral users

Boreal Genomics announces completion of $18 million Series C financing round

Cynvenio launches ClearID Breast Cancer monitoring program

Obamacare winners and losers

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

First Edition: October 1, 2013

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Researchers discover how aspirin improves survival in patients with colon cancer

Health expenditure link to cancer survival in Europe

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

Older women living in poorest areas of Appalachia have higher incidence of later stage breast cancer

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News